TrialEsophagus : official journal of the Japan Esophageal Society2022

First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590.

Takashi Kojima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.